The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection

European Respiratory Journal

Volumn 28, Issue 1, 2006, Pages 1-3

  Davies, Peter D O ^a   Drobniewski, F ^b  

^a Tuberculosis Research and Resources Centre   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; SECRETORY PROTEIN; TUBERCULIN;

BACTERIUM CULTURE; BLOOD ANALYSIS; CELL ASSAY; CONTACT EXAMINATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; EXTRAPULMONARY TUBERCULOSIS; FALSE POSITIVE RESULT; FOOD AND DRUG ADMINISTRATION; GERMANY; GOLD STANDARD; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; INFECTION CONTROL; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MATERIALS HANDLING; MEDICAL LITERATURE; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; POLICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN INDURATION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUBERCULIN TEST;

CHEMISTRY, CLINICAL; COST-BENEFIT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC TESTS; HUMANS; INTERFERON TYPE II; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33749517431     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00047606     Document Type: Editorial

References (11)

1. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
2. Health Protection Agency. Tuberculosis. www.hpa.org.uk/infections/ topics_az/tb/menu.htm. Date last updated: December 2005. Date last accessed: February 24 2006.
3. Diel R, Ernst M, Döscher G, et al. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 2006; 28: 16-23.
4. Lee JY, Choi HJ, Park I-N, et al. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
5. Piana F, Codecasa LR, Cavallerio P, et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006; 28: 31-34.
6. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
7. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
8. Morbidity and Mortality Weekly Report. Recommendations from the National Tuberculosis Controllers Association and CDC Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis December 16, 2005/54(RR15);1-37.www.cdc.gov/mmwr/preview/mmwrhtml/ rr5415a1.htm. Date last updated: December 16, 2006; Date last accessed: February 21, 2006.
9. Diel R, Nienhaus A, Lange C, Schaberg T. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 2006; 28: 35-44.
10. Wrighton-Smith P, Zellweger J-P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006; 28: 45-50.
11. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. A clinical guideline for the NHS in England and Wales. National Collaborating Centre for Chronic conditions the Royal College of Physicians (In Press).